BIOL

Biolase, Inc.
BIOL

Overview Fund Activity
Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

21 hedge funds and large institutions have $2.07M invested in Biolase, Inc. in 2020 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.

Holders
21
Holders Change
–
Holders Change %
0%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$252K
2
Jane Street
2
Jane Street
New York
$50K
3
ICM
3
Invenomic Capital Management
Massachusetts
$26K
4
ECM
4
ETrade Capital Management
Virginia
$17K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$468K

Top Sellers

1
OIM
1
Oracle Investment Management
Connecticut
$1M
2
ACM
2
Archon Capital Management
Washington
$0
3
WPC
3
White Pine Capital
Minnesota
$0
4
WVP
4
Worth Venture Partners
New Jersey
$0
5
BlackRock
5
BlackRock
New York
$125K
Name Holding Trade Value Shares
Change 		Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
– -$2K -2 Closed
1
2